Navigation Links
Intercell AG Announces Q3 2010 Results and Updates on R&D Progress and Management
Date:11/9/2010

vaccine being produced for the U.S. military. U.S. military sales in 2010 depend on further use of residual product stock of JE-Vax®. A significant increase in sales is possible for 2011, when leftover inventory of JE-Vax is expected to be exhausted or abandoned.

The Department of Health, Government of the Hong Kong Special Administrative Regions has approved Intercell's vaccine to prevent Japanese Encephalitis. The licensure process has been initiated for additional territories, and further recommendations are expected also for other key countries in Europe. These recommendations are essential to continue advancing product awareness and market growth.

The pediatric Phase III studies for IXIARO/JESPECT for use in children travelling to endemic areas are progressing according to plan, with data expected in 2012. These studies are the basis for a label extension to make the existing vaccine available for travelling children.

Based on Intercell's technology a novel JE vaccine candidate is also being developed for the endemic markets, where the WHO recommends that Japanese Encephalitis vaccination be integrated into national immunization programs. Clinical development in endemic areas is progressing, with a pivotal Phase III trial in children scheduled to start by the end of 2010 / early 2011 sponsored and managed by Intercell's partner, Biological E., in India.

Leading R&D portfolio in hospital infectionsA Phase II clinical trial involving IC43, the vaccine candidate against infections with the bacterium Pseudomonas aeruginosa, met primary immunogenicity and safety endpoints; a statistically significant reduction in mortality compared to placebo was observed for the non-adjuvanted vaccine group. If confirmed by pivotal clinical trials, this could make IC43 an important vaccine for ICU patients who are subject to a particularly high mortality risk associated with hospital-acquired infections. The vaccine generated a good immune r
'/>"/>

SOURCE Intercell AG
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Intercell Reports Positive Results From Its Phase II Pseudomonas Aeruginosa Investigational Vaccine Study for Certain Hospital-Acquired Infections
2. Romark and Intercell Join Forces in Combining Therapies Against Hepatitis C
3. Intercell and Romark Join Forces in Combining Therapies Against Hepatitis C
4. Intercell AG Appoints Staph Leavenworth Bakali as Chief Business Officer
5. Intercell Acquires Antibody Technology Platform to Further Exploit Its Capabilities to Combat Infectious Diseases
6. Intercell AG Announces First Subject Enrolled in a Phase II Trial for the Further Development of Its Investigational Vaccine Enhancement Patch to Improve Pandemic Influenza Prevention in Collaboration With U.S. Department of Health and Human Services (HHS
7. Intercell Starts a Phase I Clinical Trial for a New Streptococcus pneumoniae Vaccine
8. Intercell AG Partners with Inclinix to Enroll 1800 Volunteers for Phase III Travelers Diarrhea Vaccine Study
9. USD 12.5 m Funding for the Development of Intercells Vaccine Patch System for Pandemic Influenza From U.S. Department of Health and Human Services (HHS)
10. Favourable Six Months Follow-Up Results From Intercells Phase II Therapeutic Hepatitis C Program
11. Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... , June 2, 2015 ... (HIT) consulting firm, today announced the celebration of ... served throughout the U.S., since its inception in ... a skillful workforce in the healthcare technology industry ... with a company-wide dedication to facilitating clients, organizational ...
(Date:6/2/2015)... -- ErgoNurse, the leader in bedside safety management solutions, and Briggs ... the United States , have formalized a partnership to ... nursing markets. ... Thousands of healthcare professionals in acute ... the ErgoNurse products to stop unnecessarily utilizing their backs for ...
(Date:6/2/2015)... 2, 2015 Oramed Pharmaceuticals Inc. ... pharmaceutical company focused on the development of oral drug ... studies performed with ORMD-0801, its orally ingestible insulin capsule ... the poster sessions in the ADA 75 th ... Boston . The poster will be attended by ...
Breaking Medicine Technology:Stoltenberg Consulting celebrates 20 years of healthcare IT consulting service 2Stoltenberg Consulting celebrates 20 years of healthcare IT consulting service 3ErgoNurse and Briggs Healthcare Positioned to Completely Eliminate the Unnecessary Cost of Healthcare-Related Back Injuries 2Oramed to Present at the American Diabetes Association 75th Scientific Sessions 2Oramed to Present at the American Diabetes Association 75th Scientific Sessions 3Oramed to Present at the American Diabetes Association 75th Scientific Sessions 4
... HistoRx, the leader in quantitative immunohistochemistry, has earned ... elements of digital microscopy standardization.  Combined with patents ... & Trademark Office advance the Company,s proprietary position ... dominant role in the industry.  ...
... Feb. 28, 2012  On February 28th, 2012, the New ... those interested in speaking at its 2012 Digital Health ... York City,s Pier Sixty. At NYeC,s ... New York City—over 600 healthcare providers, healthcare technology companies, ...
Cached Medicine Technology:HistoRx Achieves Dominant Intellectual Property Position in Standardization of Results from Digital Pathology Instruments 2HistoRx Achieves Dominant Intellectual Property Position in Standardization of Results from Digital Pathology Instruments 3Call for Speakers: New York's Digital Health Conference 2012 2
(Date:6/2/2015)... UCLA Health and Exer have completed negotiations ... expand urgent care services in Los Angeles County. ... of California Board of Regents and the Exer Board ... to purchase a minority share of four existing Exer ... and Northridge and creates opportunity to grow and develop ...
(Date:6/2/2015)... Gujarat, India (PRWEB) June 02, 2015 ... finalist in the 2015 Microsoft Worldwide Small and Midsized ... global field of top Microsoft partners for demonstrating excellence ... Microsoft technology. , “This comes as no surprise ... are recognized third year consecutively at worldwide level by ...
(Date:6/2/2015)... Grenoble, France, and Dallas, TX, USA (PRWEB) June 02, ... of innovative nano and microsystems, is deploying its growth ... healthcare applications, focusing on BioMEMS: “In Yole Développement’s May ... that the BioMEMS market will grow sharply and reach ... MEMS & Sensors at Yole Développement . , ...
(Date:6/2/2015)... MI (PRWEB) June 02, 2015 Erbelli’s ... new website to promote its handmade gourmet pizzas and ... even though the website is new, the recipes are ... since 1995. The main feature of the site is ... appetizing pictures and descriptions of all the items. You ...
(Date:6/2/2015)... HILLSBORO, OR (PRWEB) June 02, 2015 ... creator of ZOOM+ Performance Health Insurance, announced today the ... Healthy Clean White 57 - a three-in-one complete dental ... Healthy Clean Jr. for kids. Like all ZOOM+ services, ... , “Why shouldn’t the dentist office be as ...
Breaking Medicine News(10 mins):Health News:UCLA Health Partners With Exer - More Than Urgent Care 2Health News:Bitscape Infotech recognized as finalist for 2015 Microsoft Worldwide small & midsized cloud solutions award. 2Health News:Bitscape Infotech recognized as finalist for 2015 Microsoft Worldwide small & midsized cloud solutions award. 3Health News:Tronics Aims to Benefit from Major Growth of Sensors and Related Technologies for Healthcare Applications 2Health News:Erbelli’s of Bradenton Launches New Mobile-Friendly Website 2Health News:ZOOM+ Opens Its First On-Demand ZOOM+Smile Studio and Reinvents the Dental Exam 2
... Healthcare and Educate Patients, SAN FRANCISCO ... Inc. and,Iverson Genetic Diagnostics, Inc. today announced ... reports for individuals receiving,Iverson,s molecular-based assay for ... DNA Direct will provide a customized,web-enabled tool ...
... from the Patient Advocate,Foundation and the Commonwealth of ... Bills When Diagnosed with a Chronic,Debilitating or Life-Threatening ... The Patient,Advocate Foundation (PAF) - a national, non-profit ... thousands of patients every year,who face access to ...
... Screening for 28 Genetic, Metabolic Conditions, HARRISBURG, Pa., ... Governor Edward G. Rendell will help to improve the ... Department., By amending the Newborn Child Testing Act ... to continue to provide for screening and follow-up,services for ...
... Howard University and,CVS/pharmacy officially opened Howard University,s ... may sharpen their skills in a,practice setting, ... and,utilize state-of-the-art technology found in many pharmacies. ... laboratory, building upon the,Company,s strong partnership with ...
... Donahue Institute Reports Economic Activity Twice as Large as Reported Last ... ... 10 A collaborative of Massachusetts,leading human services associations today lauded a ... of the state,s human services industry could be as high as,$437 million, ...
... on Tuesday, July 29, 2008, Presenting at the BMO ... ... CINCINNATI, July 10 LCA-Vision Inc. (Nasdaq:,LCAV), a leading provider ... upcoming investment community events., Second Quarter 2008 Financial Results, ...
Cached Medicine News:Health News:DNA Direct and Iverson Genetics Announce Partnership to Provide Personalized Patient Reports for Warfarin Dosing Test Results 2Health News:DNA Direct and Iverson Genetics Announce Partnership to Provide Personalized Patient Reports for Warfarin Dosing Test Results 3Health News:1,000th Uninsured Virginia Patient Secures Access to Quality Medical Care Through Virginia Cares Uninsured Program (VCUP) 2Health News:1,000th Uninsured Virginia Patient Secures Access to Quality Medical Care Through Virginia Cares Uninsured Program (VCUP) 3Health News:New Law Signed by Governor Rendell Expands Newborn Screening in Pennsylvania 2Health News:Howard University and CVS/pharmacy Announce Ribbon Cutting for the Howard University Pharmacy Practice Laboratory 2Health News:Howard University and CVS/pharmacy Announce Ribbon Cutting for the Howard University Pharmacy Practice Laboratory 3Health News:New Study Shows Human Services Impact May Be $430 Million 2Health News:LCA-Vision Announces Upcoming Investment Community Events 2
Force 1C has a streamlined, compact design perfect for the requirements of outpatient surgery - as well as the power and performance features needed for a full range of general inpatient surgical pro...
... Isolated ESU on the market with 10,000V PTP ... that allows the surgeon to adjust power settings ... pencil. Excalibur Plus PC Patented Controlled Output Voltage ... cutting through various impedance tissues with minimal thermal ...
Diamond phaco knife keratome shaped blade straight. 3.2 mm wide....
Sabre 180, 230V, 50Hz is a powerful niche generator....
Medicine Products: